Bangkok Lab & Cosmetic PCL
Bangkok Lab And Cosmetic Public Company Limited manufactures and distributes pharmaceuticals and medicinal chemical products for humans and animals in Thailand, Laos, Cambodia, Hongkong, Myanmar, and internationally. The company distributes food supplements, cosmeceuticals, cosmetic, and pharmaceutical products; medicine, medical supplies, tonics, and supplements for animals; and supplementary fo… Read more
Bangkok Lab & Cosmetic PCL (BLC) - Total Liabilities
Latest total liabilities as of June 2024: ฿544.58 Million THB
Based on the latest financial reports, Bangkok Lab & Cosmetic PCL (BLC) has total liabilities worth ฿544.58 Million THB as of June 2024.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Bangkok Lab & Cosmetic PCL - Total Liabilities Trend (2021–2023)
This chart illustrates how Bangkok Lab & Cosmetic PCL's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Bangkok Lab & Cosmetic PCL Competitors by Total Liabilities
The table below lists competitors of Bangkok Lab & Cosmetic PCL ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
TWay Holdings
KO:004870
|
Korea | ₩30.99 Billion |
|
Inch Kenneth Kajang Rubber PLC
KLSE:2607
|
Malaysia | RM122.86 Million |
|
Compania General de Electricidad SA
SN:CGE
|
Chile | CL$2.57 Trillion |
|
Diamond Citra Propertindo PT
JK:DADA
|
Indonesia | Rp287.56 Billion |
|
FN REPUBLIC Co. Ltd
KQ:064090
|
Korea | ₩3.75 Billion |
|
Galane Gold Ltd
OTCQB:GGGOF
|
USA | $14.61 Million |
|
Senetas Corporation Ltd
AU:SEN
|
Australia | AU$16.74 Million |
|
Aqua Metals Inc
NASDAQ:AQMS
|
USA | $3.98 Million |
Liability Composition Analysis (2021–2023)
This chart breaks down Bangkok Lab & Cosmetic PCL's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 4.43 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.34 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.25 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Bangkok Lab & Cosmetic PCL's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Bangkok Lab & Cosmetic PCL (2021–2023)
The table below shows the annual total liabilities of Bangkok Lab & Cosmetic PCL from 2021 to 2023.
| Year | Total Liabilities | Change |
|---|---|---|
| 2023-12-31 | ฿644.92 Million | -30.74% |
| 2022-12-31 | ฿931.12 Million | +6.79% |
| 2021-12-31 | ฿871.90 Million | -- |